New imaging agent could sharpen detection of spread prostate cancer
NCT ID NCT03173924
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 22 times
Summary
This study tests whether a new radioactive tracer called 18F-DCFPyL can better detect prostate cancer that has spread compared to a standard tracer. About 96 adults with metastatic prostate cancer will receive both types of PET/CT scans. Researchers will check how accurate the new tracer is at finding tumors, and may confirm results with biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.